Skip to main content
ConductScienceScienceDex

Fares Qeadan

NIH Rank #8426
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 12645451Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Public Health

NIH Funding · FY2025

Linked Award Amount
$1.7M
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#8,426
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Fares Qeadan. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Fares Qeadan as a PI. Multi-PI records show the full award amount for context.

  • 4R01DA057658-02R01
    Weighting Longitudinal Data to Access Opioid Analgesia Tapering Outcomes among Patients with Co-occurring Chronic Pain and Substance Use Disorder
    Loyola University Chicago
    $680.5K
    award amount
  • 4R33DA049382-04R33
    Leveraging CDC Opioid Overdose Surveillance Funding from the Albuquerque Area Southwest Tribal Epidemiology Center to Create Tribal Data and Culturally Center Medications for Opioid Use Disorder
    Loyola University Chicago
    $648.3K
    award amount
  • 5R01AA031890-02R01
    Advancing Integrated Treatment for Co-Occurring Opioid and Alcohol Use Disorders: A Comprehensive Analysis of GLP-1 Receptor Agonists and Traditional Pharmacotherapies in Real-World Settings
    Loyola University Chicago
    $385K
    award amount

Award organization

Organizations that administered FY2025 awards listing Fares Qeadan as a PI.

FY2025 award administered by Loyola University Chicago (IL).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Loyola University Chicago
  2. 2025
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2025
    $2M Cumulative Funding
  5. 2025
    Entered Top 50% Nationally
    Ranked #8426
  6. 2025
    R01 Grant Holder
  7. 2026
    Entered Top 25% Nationally
    Ranked #3646

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Fares Qeadan.

Erin F Madden
Loyola University Chicago
2
shared awards
Kamilla L. Venner
Loyola University Chicago
2
shared awards

Explore further

Find collaborators for Fares Qeadan

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →